[{"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":2258000000.0,"RevenuesConverted_1_FY_USD":11068000000.0,"RevenuesConverted_4_FY_USD":42518000000.0,"CommonStockDividendsPerShareDeclared_1_FY_USD":0.49,"CommonStockDividendsPerShareDeclared_4_FY_USD":1.84,"CommonStockSharesConverted_0_FY_shares":2900000000.0,"Assets_0_FY_USD":118481000000.0,"NetIncomeLossConverted_4_FY_USD":-8995000000.0,"StockholdersEquity_0_FY_USD":37822000000.0,"EarningsPerShareDiluted_4_FY_USD":-3.99,"EarningsPerShareDiluted_1_FY_USD":-4.45,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":14052000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":2258000000.0,"StockholdersEquityConverted_0_FY_USD":37882000000.0,"NetIncomeLossConverted_1_FY_USD":-10027000000.0,"EarningsPerShareBasic_4_FY_USD":-3.99,"EarningsPerShareBasic_1_FY_USD":-4.45,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210210"}]